HUP0001263A2 - Eljárások anti-CD4OL vegyületek gyógyászati alkalmazásaira - Google Patents

Eljárások anti-CD4OL vegyületek gyógyászati alkalmazásaira

Info

Publication number
HUP0001263A2
HUP0001263A2 HU0001263A HUP0001263A HUP0001263A2 HU P0001263 A2 HUP0001263 A2 HU P0001263A2 HU 0001263 A HU0001263 A HU 0001263A HU P0001263 A HUP0001263 A HU P0001263A HU P0001263 A2 HUP0001263 A2 HU P0001263A2
Authority
HU
Hungary
Prior art keywords
compounds
cd4ol
methods
therapeutic administration
immune system
Prior art date
Application number
HU0001263A
Other languages
English (en)
Inventor
Susan L. Kalled
David W. Thomas
Original Assignee
Biogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Inc. filed Critical Biogen, Inc.
Publication of HUP0001263A2 publication Critical patent/HUP0001263A2/hu
Publication of HUP0001263A3 publication Critical patent/HUP0001263A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

A találmány tárgya anti-CD40L vegyület alkalmazása krónikűsimműnrendszeri rendellenességben vagy aűtőimműn betegségben szenvedőpáciensek kezelésére alkalmas, vagy a páciensbe átültetett szövetkilökődését gátló, vagy transzgenikűs termékkel szemben kialakűltimműnreakció elnyőmására alkalmas gyógyszer előállítására. Anti-CD40Lvegyületek hárőmhetenkénti vagy ritkábban történő beadásával sikeresenkezelhetőek imműnrendszeri zavarők. ŕ
HU0001263A 1997-03-07 1998-01-09 Methods of therapeutic administration of anti-cd4ol compounds HUP0001263A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4015497P 1997-03-07 1997-03-07

Publications (2)

Publication Number Publication Date
HUP0001263A2 true HUP0001263A2 (hu) 2000-08-28
HUP0001263A3 HUP0001263A3 (en) 2005-11-28

Family

ID=21909414

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001263A HUP0001263A3 (en) 1997-03-07 1998-01-09 Methods of therapeutic administration of anti-cd4ol compounds

Country Status (3)

Country Link
AU (1) AU5623398A (hu)
HU (1) HUP0001263A3 (hu)
WO (1) WO1998039026A2 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2089229C (en) 1992-02-14 2010-04-13 Alejandro A. Aruffo Cd40cr receptor and ligands therefor
CN1173735C (zh) * 1998-04-03 2004-11-03 达特茅斯学院理事 抗-gp39抗体在狼疮及相关肾病的治疗和/或逆转中的应用
EP1101495A4 (en) * 1999-06-01 2003-05-07 Eisai Co Ltd PREVENTIVE AGENTS AGAINST IDIOPATHIC THROMOBOCYTOPENIC PURPURA
JP2003510371A (ja) * 1999-10-04 2003-03-18 カイロン コーポレイション 乾癬を処置するためのｃｄ４０アンタゴニスト
EP1839674A1 (en) * 1999-10-04 2007-10-03 Novartis Vaccines and Diagnostics, Inc. CD40 antagonist for treating psoriasis
MXPA02004599A (es) * 1999-11-08 2002-10-23 Idec Pharma Corp Tratamiento de tumores malignos de celula b utilizando anticuerpos anti-cd40l en combinacion con anticuerpos anti-cd20 y/o agentes quimioterapeuticos y radioterapia.
EP1262194A4 (en) * 2000-03-06 2003-05-07 Eisai Co Ltd HEALING AND PREVENTIVE AGENTS FOR THE ANTIPHOSPHOLIPID-ANTIBODY SYNDROME
WO2001079555A2 (en) 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
CA2408408C (en) 2000-05-12 2013-07-09 Genzyme Corporation Modulators of tnf- alpha signaling
WO2001087310A1 (en) * 2000-05-18 2001-11-22 Biotransplant, Inc. Process for reducing antibody response against xenografts
AU8867501A (en) * 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
KR20040023565A (ko) * 2000-09-18 2004-03-18 아이덱 파마슈티칼즈 코포레이션 Ｂ 세포 고갈/면역조절 항체 조합을 이용한 자가면역질환의 치료를 위한 조합 요법
PT1567138E (pt) 2002-11-21 2011-04-11 Genzyme Corp Utilização de derivados de diamida para inibição de rejeição crónica de transplante
JP4914008B2 (ja) * 2002-11-21 2012-04-11 ジェンザイム・コーポレーション 免疫寛容を誘導するためのジアミド誘導体と免疫抑制剤との組み合わせ

Also Published As

Publication number Publication date
AU5623398A (en) 1998-09-22
WO1998039026A2 (en) 1998-09-11
HUP0001263A3 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
HUP0001263A2 (hu) Eljárások anti-CD4OL vegyületek gyógyászati alkalmazásaira
RU94045155A (ru) Способы ингибирования болезни альцгеймера
EA200501496A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
DK1263729T3 (da) Cykliske azaforbindelser til anvendelse til behandling af serotoninrealterede sygdomme
EA200000468A1 (ru) Терапевтическая композиция для введения толтеродина с контролируемым высвобождением
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
DK0723444T3 (da) Levobupivacain, som er egnet til behandling af kronisk smerte
MX2007013876A (es) Uso de inhibidor de la via del factor de tejido para tratar infecciones bacterianas severas.
MXPA04003548A (es) Tratamiento de neumonia severa mediante administracion de inhibidor de via factor de tejido.
IL192287A0 (en) Pharmaceutical compositions and methods for use
MX2008013635A (es) Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
IL130785A0 (en) Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with an autoimmune disease or chronic immune system disorder and pharmaceutical compositions containing the same
RU2003125274A (ru) Применение флумазенила в производстве лекарства для лечения алкогольной зависимости
ATE77751T1 (de) Mittel zur behandlung von knochenkrankheiten.
Olujohungbe et al. Does erythropoietin accelerate malignant transformation in multiple myeloma?
HUP0003256A2 (hu) Pentozán-poliszulfát és sói alkalmazása krónikus progresszív érhegesedéssel járó betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
WO2002094199A3 (en) METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
MX2021001985A (es) Metodos agnosticos de conteo de plaquetas para tratar la mielofibrosis.
DE69926794D1 (de) Ponazuril zur behandlung von durch coccidia neurologischen und "abortigenic" verursachten erkrankungen
NO20024683L (no) Terapier med oppdelte doser som har vaskulirt skadende aktivitet
Filos et al. Analgesia with epidural nimodipine
SU1607814A1 (ru) Способ лечени эпилепсии
ATE248607T1 (de) Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
SG150552A1 (en) Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi)